Literature DB >> 500751

The results of reinsertion of a total hip prosthesis after sepsis.

G A Hunter.   

Abstract

Sixty-five total hip arthroplastics were reinserted after sepsis around the hip, positive cultures being obtained from fifty-six. Although 65 per cent of patients still have their implant in position, only sixteen of sixty-five (25 per cent) show an excellent or good result on a Harris rating. Twenty-three of sixty-five (35 per cent) subsequently required an excision arthroplasty. The indications and contraindications for this procedure are given.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500751

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  7 in total

1.  [One stage revision of infected total hip replacements with replacement of bone loss by allografts. Study of 90 cases of which 46 used bone allografts].

Authors:  B Loty; M Postel; J Evrard; P Matron; J P Courpied; M Kerboull; B Tomeno
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

2.  Reconstructive surgery of the lower extremity.

Authors:  R J Claridge
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

3.  Resection arthroplasty: middle- and long-term results.

Authors:  T Herzog; W Link; S Engel; H Beck
Journal:  Arch Orthop Trauma Surg       Date:  1989       Impact factor: 3.067

4.  Rearthroplasty after conventional total hip prosthesis and double-cup prosthesis. A comparative study.

Authors:  A Reigstad; K R Hetland
Journal:  Arch Orthop Trauma Surg       Date:  1984

5.  Infected hip prostheses.

Authors: 
Journal:  Br Med J       Date:  1980-05-24

6.  Role of frozen section histology in diagnosis of infection during revision arthroplasty.

Authors:  A D Musso; K Mohanty; R Spencer-Jones
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

7.  A Case of Nongerminomatous Germ Cell Tumor of the Pineal Region: Risks and Advantages of Biopsy by Endoscopic Approach.

Authors:  Mauro Dobran; Davide Nasi; Fabrizio Mancini; Maurizio Gladi; Massimo Scerrati
Journal:  Case Rep Med       Date:  2018-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.